Proteomic analysis of ganglioside-associated membrane molecules: Substantial basis for molecular clustering

Proteomics

Volumn 12, Issue 21, 2012, Pages 3154-3163

  Hashimoto, Noboru ^a   Hamamura, Kazunori ^a   Kotani, Norihiro ^b   Furukawa, Keiko ^a,c   Kaneko, Kei ^a   Honke, Koichi ^b   Furukawa, Koichi ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KOCHI MEDICAL SCHOOL   (Japan)

^c CHUBU UNIVERSITY   (Japan)

Author keywords

EMARS; Glycosphingolipid; Lipid raft; Mass spectrometry; Melanoma

Indexed keywords

GANGLIOSIDE GD3; GLYCOLIPID; NEOGENIN; TRITON X 100;

ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MEMBRANE; MOLECULE; PRIORITY JOURNAL; PROTEOMICS; SUCROSE DENSITY GRADIENT CENTRIFUGATION;

CELL LINE, TUMOR; GANGLIOSIDES; HUMANS; MASS SPECTROMETRY; MELANOMA; MEMBRANE MICRODOMAINS; MEMBRANE PROTEINS; PROTEOME; PROTEOMICS;

EID: 84868099850     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201200279     Document Type: Article

References (37)

1. Wiegandt, H., in: Wiegandt, H. (Ed.), Gangliosides in Glycolipids, Elsevier, New York, 1985, pp. 199-260.
2. Yu, R. K., Nakatani, Y., Yanagisawa, M., The role of glycosphingolipid metabolism in the developing brain. J. Lipid Res. 2009, 50(Suppl), S440-S445.
3. Pukel, C. S., Lloyd, K. O., Travassos, L. R., Dippold, W. G. et al., GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibody. J. Exp. Med. 1982, 155, 1133-1147.
4. Saarinen, U. M., Coccia, P. F., Gerson, S. L., Pelley, R. et al., Eradication of neuroblastoma cells in vitro by monoclonal antibody and human complement: method for purging autologous bone marrow. Cancer Res. 1985, 45, 5969-5975.
5. Furukawa, K., Tokuda, N., Okuda, T., Tajima, O. et al., Glycosphingolipids in engineered mice: insights into function. Semin. Cell Dev. Biol. 2004, 15, 389-396.
6. Inoue, M., Fujii, Y., Furukawa, K., Okada, M. et al., Refractory skin injury in the complex knock-out mice expressing only GM3 ganglioside. J. Biol. Chem. 2002, 277, 29881-29888.
7. Hamamura, K., Furukawa, K., Hayashi, T., Hattori, T. et al., Ganglioside GD3 promotes cell growth and invasion through p130Cas and paxillin in malignant melanoma cells. Proc. Natl. Acad. Sci. USA 2005, 102, 11041-11046.
8. Yoshida, S., Fukumoto, S., Kawaguchi, H., Sato, S. et al., Ganglioside GD2 in small cell lung cancer cell lines: enhancement of cell proliferation and mediation of apoptosis. Cancer Res. 2001, 61, 4244-4252.
9. Cazet, A., Bobowski, M., Rombouts, Y., Lefebvre, J. et al., The ganglioside GD2 induces the constitutive activation of c-Met in MDA-MB-231 breast cancer cells expressing the GD3 synthase. Glycobiology 2012, 22, 806-816.
10. Simons, K., Ikonen, E., Functional rafts in cell membranes. Nature 1997, 387, 569-572.
11. Hakomori, S. I., Cell adhesion/recognition and signal transduction through glyco- sphingolipid microdomain. Glycoconj. J. 2000, 17, 143-151.
12. Lingwood, D, Simons, K., Lipid rafts as a membrane-organizing principle. Science 2010, 327, 46-50.
13. Furukawa, K., Hamamura, K., Nakashima, H., Furukawa, K., Molecules in the signaling pathway activated by gangliosides can be targets of therapeutics for malignant melanomas. Proteomics 2008, 8, 3312-3316.
14. Ohkawa, Y., Miyazaki, S., Hamamura, K., Kambe, M. et al., Ganglioside GD3 enhances adhesion signals and augments malignant properties of melanoma cells by recruiting integrins to glycolipid-enriched microdomains. J. Biol. Chem. 2010, 285, 27213-272123.
15. Hamamura, K., Tsuji, M., Hotta, H., Ohkawa, Y. et al., Functional activation of Src family kinase yes protein is essential for the enhanced malignant properties of human melanoma cells expressing ganglioside GD3. J. Biol. Chem. 2011, 286, 18526-18537.
16. Nakano, J., Raj, B. K., Asagami, C., Lloyd, K. O., Human melanoma cell lines deficient in GD3 ganglioside expression exhibit altered growth and tumorigenic characteristics. J. Invest. Dermatol. 1996, 107, 543-548.
17. Kotani, N., Gu, J., Isaji, T., Udaka, K. et al., Biochemical visualization of cell surface molecular clustering in living cells. Proc. Natl. Acad. Sci. USA 2008, 105, 7405-7409.
18. Jiang, S., Kotani, N., Ohnishi, T., Miyagawa-Yamguchi, A. et al., A proteomics approach to the cell-surface interactome using the enzyme-mediated activation of radical sources reaction. Proteomics 2012, 12, 54-62.
19. Masuda, T., Tomita, M., Ishihama, Y., Phase transfer surfactant-aided trypsin digestion for membrane proteome analysis. J. Proteome Res. 2008, 7, 731-740.
20. Iwasaki, M., Masuda, T., Tomita, M., Ishihama, Y., Chemical cleavage-assisted tryptic digestion for membrane proteome analysis. J. Proteome Res. 2009, 8, 3169-3175.
21. Amano, M., Tsumura, Y., Taki, K., Harada, H., Mori, K. et al., A proteomic approach for comprehensively screening substrates of protein kinases such as rho-kinase. PLoS One 2010, 5, e8704.
22. Turiák, L., Misják, P., Tamás, G., Szabó, T. G. et al., Proteomic characterization of thymocyte-derived microvesicles and apoptotic bodies in BALB/c mice. J. Proteom. 2011, 74, 2025-2033.
23. Keller, A., Nesvizhskii, A. I., Kolker, E., Aebersold, R., Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal. Chem. 2002, 74, 5383-5392.
24. Nesvizhskii, A. I., Keller, A., Kolker, E., Aebersold, R., A statistical model for identifying proteins by tandem mass spectrometry. Anal. Chem. 2003, 75, 4646-4658.
25. Nakashima, H., Hamamura, K., Houjou, T., Taguchi, R. et al., Overexpression of caveolin-1 in a human melanoma cell line results in dispersion of ganglioside GD3 from lipid rafts and alteration of leading edges, leading to attenuation of malignant properties. Cancer Sci. 2007, 98, 512-520.
26. Bae, G. U., Yang, Y. J., Jiang, G., Hong, M. et al., Neogenin regulates skeletal myofiber size and focal adhesion kinase and extracellular signal-regulated kinase activities in vivo and in vitro. Mol. Biol. Cell. 2009, 20, 4920-4931.
27. Shih, I. M., The role of CD146 (Mel-CAM) in biology and pathology. J. Pathol. 1999, 189, 4-11.
28. Hamamura, K., Tsuji, M., Nakashima, H., Miyazaki, S. et al., Focal adhesion kinase as well as p130Cas and paxillin is crucially involved in the enhanced malignant properties under expression of ganglioside GD3 in melanoma cells. Biochim. Biophys. Acta. 2008, 1780, 513-519.
29. Simons, K., Gerl, M. J., Revitalizing membrane rafts: new tools and insights. Nat. Rev. Mol. Cell. Biol. 2010, 11, 688-699.
30. Jacobson, K., Mouritsen, O. G., Anderson, R. G., Lipid rafts: at a crossroad between cell biology and physics. Nat. Cell Biol. 2007, 9, 7-14.
31. Baruthio, F., Quadroni, M., Rüegg, C., Mariotti, A., Proteomic analysis of membrane rafts of melanoma cells identifies protein patterns characteristic of the tumor progression stage. Proteomics 2008, 8, 4733-4747.
32. Chen, E. I., Cociorva, D., Norris, J. L., Yates, J. R., 3rd., Optimization of mass spectrometry-compatible surfactants for shotgun proteomics. J. Proteome Res. 2007, 6, 2529-3258.
33. Munro, S., Lipid rafts: elusive or illusive? Cell 2003, 115, 377-388.
34. Fancy, D. A., Elucidation of protein-protein interactions using chemical cross-linking or label transfer techniques. Curr. Opin. Chem. Biol. 2000, 4, 28-33.
35. Brunner, J., New photolabeling and crosslinking methods. Annu. Rev. Biochem. 1993, 62, 483-514.
36. Mishra, S., Joshi, P. G., Lipid raft heterogeneity: an enigma. J. Neurochem. 2007, 103 (Suppl 1), 135-142.
37. Lingwood, D., Kaiser, H. J., Levental, I., Simons, K., Lipid rafts as functional heterogeneity in cell membranes. Biochem. Soc. Trans. 2009, 37 (Pt 5), 955-960.